Changes in p21(WAF1), pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus

European Journal of Cancer

Volumn 36, Issue 2, 2000, Pages 249-256

  Huang, T G ^a   Ip, S M ^a   Yeung, W S B ^a   Ngan, H Y S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adenoviral vector; Bax Bcl 2; Cervical cancer cell lines; Growth arrest apoptosis; Mdm2; p21(WAF1); p53; pRb

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; BAX PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; MDM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UTERINE CERVIX CANCER; ADENOVIRUS; CELL CULTURE; FEMALE; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR;

ADENOVIRIDAE; BCL-2-ASSOCIATED X PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENES, P53; GENETIC VECTORS; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; RETINOBLASTOMA PROTEIN; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0033621992     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00247-6     Document Type: Article

References (28)

1. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
2. Wang X.W., Harris C.C. TP53 tumour suppressor gene. clues to molecular carcinogenesis and cancer therapy Cancer Surv. 28:1996;169-196.
3. Haupt Y., Rowan S., Oren M. p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene. 10:1995;1563-1571.
4. Baker S.J., Markowitz S., Fearon E.R., Willson J.K., Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 249:1990;912-915.
5. Liu T.J., el Naggar A.K., McDonnell T.J.et al. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 55:1995;3117-3122.
6. Nielsen L.L., Dell J., Maxwell E., Armstrong L., Maneval D., Catino J.J. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene. Ther. 4:1997;129-138.
7. Ko L.J., Prives C. p53. puzzle and paradigm Genes Dev. 10:1996;1054-1072.
8. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
9. Nevins J.R. E2F. a link between the Rb tumor suppressor protein and viral oncoproteins Science. 258:1992;424-429.
10. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
11. White E., Chiou S.K., Rao L., Sabbatini P., Lin H.J. Control of p53-dependent apoptosis by E1B, Bcl-2, and Ha-ras proteins. Cold Spring Harbor Symp. Quant. Biol. 59:1994;395-402.
12. Fuchs E.J., McKenna K.A., Bedi A. p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta. Cancer Res. 57:1997;2550-2554.
13. Canman C.E., Gilmer T.M., Coutts S.B., Kastan M.B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:1995;600-611.
14. Haas Kogan D.A., Kogan S.C., Levi D.et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:1995;461-472.
15. Waldman T., Zhang Y., Dillehay L.et al. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med. 3:1997;1034-1036.
16. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 362:1993;857-860.
17. Oren M., Prives C. p53. upstream, downstream and off stream. Review of the 8th p53 workshop (Dundee, July 5-9, 1996) Biochim. Biophys. Acta. 1288:1996;R13-19.
18. Polyak K., Waldman T., He T.C., Kinzler K.W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1996;1945-1952.
19. Bissonnette N., Hunting D.J. p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene. 16:1998;3461-3469.
20. Graham F.L., Prevec L. Methods for construction of adenovirus vectors. Mol. Biotechnol. 3:1995;207-220.
21. Okorokov A.L., Ponchel F., Milner J. Induced N- and C-terminal cleavage of p53. a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53 EMBO J. 16:1997;6008-6017.
22. Gorospe M., Cirielli C., Wang X., Seth P., Capogrossi M.C., Holbrook N.J. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14:1997;929-935.
23. Macleod K.F., Sherry N., Hannon G.et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:1995;935-944.
24. Gervais J.L., Seth P., Zhang H. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J. Biol. Chem. 273:1998;19207-19212.
25. Hinds P.W. The retinoblastoma tumor suppressor protein. Curr. Opin. Genet. Dev. 5:1995;79-83.
26. Janicke R.U., Walker P.A., Lin X.Y., Porter A.G. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15:1996;6969-6978.
27. Chen L., Marechal V., Moreau J., Levine A.J., Chen J. Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J. Biol. Chem. 272:1997;22966-22973.
28. Knudson C.M., Tung K.S., Tourtellotte W.G., Brown G.A., Korsmeyer S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science. 270:1995;96-99.